Table 2B.

Raw and PSD-adjusted scores for FM+ patients diagnosed with RA or FM.

VariablesUnadjusted PSDDifferences
RA, n = 2642, Mean (SD) or %FM, n = 806, Mean (SD) or %Unadjusted DifferenceUnadjusted ESAdjusted Difference
Figure 2
  Pain, 0–106.4 (2.2)6.6 (2.1)−0.170.09−0.06
  Global, 0–106.0 (2.1)6.1 (2.0)−0.090.040.02
  HAQ, 0–31.6 (0.6)1.3 (0.6)0.26−0.450.27
  QoL, 100–0*52.3 (18.5)51.9 (19.1)0.75−0.020.22
Figure 3
  WPI, 0–1913.2 (4.4)13.7 (5.7)−0.440.110.34
  SSS, 0–127.6 (1.9)8.2 (2.0)−0.530.320.34
  Symptoms, 0–3615.1 (6.4)16.6 (6.1)−1.290.24−0.86
  Joint count, 0–1814.4 (3.8)12.8 (4.6)1.620.381.80
Figure 4
  Opioids49.953.6−3.380.87Δ−2.69
  Pregabalin7.321.7−14.150.29Δ−12.26
  Prednisone34.26.127.697.72Δ−26.20
  Smoking16.120.5−4.090.75Δ−4.46
Other variables
  BMI31.1 (8.2)32.1 (8.0)−0.710.11−0.50
  Income, US$44,952 (30,547)44,379 (30,129)1103−0.02−398
  PCS, 100–0*28.7 (7.6)29.6 (97.6)−0.900.13−0.98
  MCS, 100–0*39.4 (11.4)38.1 (11.6)1.140.110.76
  College*29.830.90.031.00Δ−0.82
  • * Lower values are more abnormal.

  • p > 0.05.

  • Adjusted and unadjusted differences refer to adjustment by PSD values, and all variables are adjusted for age and sex.

  • Δ Unadjusted OR. FM: fibromyalgia; RA: rheumatoid arthritis; PSD: polysymptomatic distress; ES: effect size; HAQ: Health Assessment Questionnaire; QoL: Quality of Life; WPI: widespread pain index; SSS: symptom severity scale; BMI: body mass index; PCS: physical component summary of Medical Outcomes Study Short Form-36 (SF-36); MCS: SF-36 mental component summary.